Liposomal delivery enhances absorption of vitamin C into plasma and leukocytes: a double-blind, placebo-controlled, randomized trial.

Ralf Jäger, Martin Purpura, Grant M Tinsley, Ashok Godavarthi, Dhananjaya Bhaskarachar

Journal: European journal of nutrition 2024;63(8):3037-3046

PMID: 39237620

Plain Language Summary

plain language summary logo

Vitamin C is important for many bodily functions, including supporting the immune system, but it can be difficult for the body to absorb effectively. The aim of this randomised control trial of 27 participants (19 men and 8 women) was to examine how well a special form of vitamin C (LipoVantage), delivered in liposomes (fat bubbles that can carry nutrients), is absorbed in the body compared to standard vitamin C.

The results showed that both forms of vitamin C were absorbed by the body. But the liposomal form of vitamin C was absorbed better into the bloodstream and white blood cells than the standard vitamin C.

It was concluded that liposomal vitamin C significantly increased vitamin C absorption in the blood and white blood cells possibly due to the protection the liposomes provide against breakdown in the gut. This study could be used by healthcare professionals to understand the potential benefits of liposomal vitamin C for improving absorption in the body.

Abstract

PURPOSE

L-Ascorbic acid (vitamin C) is an essential water-soluble vitamin that plays an important role in various physiological functions, including immune health. The stability of vitamin C in the gastrointestinal tract its bioavailability is limited. This study aimed to investigate if a liposomal form of vitamin C can increase absorption compared to standard vitamin C.

METHODS

In a randomized, double-blind, placebo-controlled, crossover fashion, 19 males and 8 females (n = 27; 36.0 ± 5.1 years, 165.0 ± 6.9 cm, 70.6 ± 7.1 kg) ingested a single-dose of placebo (PLA), 500 mg vitamin C (VIT C), and 500 mg liposomal vitamin C (LV-VIT C, LipoVantage, Specnova, LLC, Tyson Corner, VA, USA). Venous blood samples were collected 0, 0.5-, 1-, 1.5-, 2-, 3-, 4-, 6-, 8-, 12-, and 24-hours after ingestion and were analyzed for plasma and leukocyte vitamin C concentration.

RESULTS

VIT C and LV-VIT C demonstrated significantly greater Cmax and AUC in plasma and in leukocytes compared to placebo (p < 0.001). Additionally, LV-VIT C had significantly higher Cmax (plasma + 27%, leukocytes + 20%, p < 0.001) and AUC (plasma + 21%, leukocytes + 8%, p < 0.001) values as compared to VIT C.

CONCLUSION

Liposomal formulation of vitamin C increases absorption into plasma and leukocytes.

TRIAL REGISTRATION

Clinical Trials Registry - India (CTRI/2023/04/051789).

© 2024. The Author(s).

Address: Increnovo LLC, 730 E Carlisle Ave, Whitefish Bay, WI, 53217, USA. [email protected].; Increnovo LLC, 730 E Carlisle Ave, Whitefish Bay, WI, 53217, USA.; Radiant Research Services Pvt. Ltd, Bangalore, 560058, India.; Department of Medicine, Shetty's Hospital, 2nd F Main Rd, Kaveri Nagar, Bommanahalli, Bengaluru, Karnataka, 560 068, India.; Energy Balance & Body Composition Laboratory, Department of Kinesiology & Sport Management, Texas Tech University, Lubbock, TX, USA.

Patient Centred Factor

Clinical Imbalances

Modifiable Lifestyle Factors

Nutrition Evidence Keywords

Bioactive Substances

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.